Cytoplasmic FBXO38 mediates PD-1 degradation

被引：1
|
作者：
Liu, Xiwei [1 ]
Meng, Xiangbo [2 ]
Lin, Zuomiao [3 ]
Jiang, Shutan [1 ]
Liu, Haifeng [1 ]
Sun, Shao-cong [4 ]
Liu, Xiaolong [1 ]
Zhou, Penghui [5 ]
Huang, Xiaowu [6 ,7 ,8 ]
Wei, Lai [9 ]
Yang, Wei [10 ,11 ]
Xu, Chenqi [1 ,3 ]
机构：
[1] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai, Peoples R China
[2] Shandong Univ, Adv Med Res Inst, Cheeloo Coll Med, Meili Lake Translat Res Pk, Jinan, Shandong, Peoples R China
[3] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Hangzhou, Peoples R China
[4] Chinese Inst Med Res, Inst Immunol, Beijing, Peoples R China
[5] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China
[6] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai 200032, Peoples R China
[7] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China
[8] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200032, Peoples R China
[9] Guangzhou Med Univ, Affiliated Hosp 2, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 510000, Peoples R China
[10] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangdong Prov Key Lab Mol Oncol Pathol, Guangzhou, Peoples R China
[11] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China
来源：
EMBO REPORTS | 2024年 / 25卷 / 10期
关键词：
MOKA;
D O I：
10.1038/s44319-024-00254-y
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Comment on “FBXO38 is dispensable for PD-1 regulation” by Dibus et al,
引用
收藏
页码：4168 / 4171
页数：4
相关论文
共 50 条
  • [21] 鸡FBXO38转录剪接体1的克隆、表达和功能分析
    张志威
    孙婴宁
    荣恩光
    李辉
    王宁
    生物化学与生物物理进展, 2013, 40 (09) : 845 - 858
  • [22] Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
    Wang, Xiaodong
    Yang, Xiaohui
    Zhang, Chang
    Wang, Yang
    Cheng, Tianyou
    Duan, Liqiang
    Tong, Zhou
    Tan, Shuguang
    Zhang, Hangjie
    Saw, Phei Er
    Gu, Yinmin
    Wang, Jinhua
    Zhang, Yibi
    Shang, Lina
    Liu, Yajuan
    Jiang, Siyuan
    Yan, Bingxue
    Li, Rong
    Yang, Yue
    Yu, Jie
    Chen, Yunzhao
    Gao, George Fu
    Ye, Qinong
    Gao, Shan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (12) : 6640 - 6650
  • [23] A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID
    Akcimen, Fulya
    Vural, Atay
    Durmus, Hacer
    Cakar, Arman
    Houlden, Henry
    Parman, Yesim G.
    Basak, A. Nazli
    JOURNAL OF HUMAN GENETICS, 2019, 64 (11) : 1141 - 1144
  • [24] FBXO38 ubiquitin ligase controls centromere integrity via ZXDA/B stability (vol 10, 929288, 2022)
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [25] A novel homozygous FBXO38 variant causes an early-onset distal hereditary motor neuronopathy type IID
    Fulya Akçimen
    Atay Vural
    Hacer Durmuş
    Arman Çakar
    Henry Houlden
    Yeşim G. Parman
    A. Nazlı Başak
    Journal of Human Genetics, 2019, 64 : 1141 - 1144
  • [26] Overcoming Acquired PD-1/PD-L1 Resistance with CD38 Blockade
    Mittal, Deepak
    Vijayan, Dipti
    Smyth, Mark J.
    CANCER DISCOVERY, 2018, 8 (09) : 1066 - 1068
  • [27] PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression!
    Mariotti, Francesca R.
    Petrini, Stefania
    Ingegnere, Tiziano
    Tumino, Nicola
    Besi, Francesca
    Scordamaglia, Francesca
    Munari, Enrico
    Pesce, Silvia
    Marcenaro, Emanuela
    Moretta, Alessandro
    Vacca, Paola
    Moretta, Lorenzo
    ONCOIMMUNOLOGY, 2019, 8 (03):
  • [28] The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation
    Lu, Yunzhe
    Li, Jiezhi
    Cheng, Dongmei
    Parameswaran, Balaji
    Zhang, Shaohua
    Jiang, Zefei
    Yew, P. Renee
    Peng, Junmin
    Ye, Qinong
    Hu, Yanfen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (49) : 41014 - 41022
  • [29] Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1)
    Wen, Biyan
    Zhao, Lin
    Wang, Yuchu
    Qiu, Chuangnan
    Xu, Zhimin
    Huang, Kunling
    Zhu, He
    Li, Zemin
    Li, Huangjin
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2020, 50 (03): : 252 - 259
  • [30] PD-1 and PD-1 ligands: from discovery to clinical application
    Okazaki, Taku
    Honjo, Tasuku
    INTERNATIONAL IMMUNOLOGY, 2007, 19 (07) : 813 - 824
12345